Mark Benger is an experienced professional in the pharmaceutical industry, currently serving as Site Director at Cambrex since January 2019. Prior to this role, Mark was Site Director at Solid Form Solutions for a brief period after its acquisition by Cambrex and served as Analytical Director at Solid Form Solutions Ltd, where responsibilities included providing analytical support for Solid State projects and advising clients on methods validation. Mark's earlier experience includes roles as Operations Manager at Exova Pharma, providing high-quality data for batch release and stability studies, and various positions at Aptuit, including Director of the Physical and Analytical Chemistry Department. Mark also held the position of Section Head for Analytical Development at Quintiles, overseeing a team focused on analytical method development for solid dosage form products.